Cargando…

Th1 ‐ CD11c (+) B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis

OBJECTIVE: Although plasmapheresis is a treatment option for patients with autoimmune neurological diseases, treatment response varies greatly among patients. The main objective of this study was to find out if biological/immune traits correlate with a beneficial response. METHODS: We thoroughly ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Kimitoshi, Lin, Youwei, Yamaguchi, Hiromi, Sato, Wakiro, Takewaki, Daiki, Minote, Misako, Doi, Yoshimitsu, Okamoto, Tomoko, Takahashi, Ryosuke, Kondo, Takayuki, Yamamura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293420/ https://www.ncbi.nlm.nih.gov/pubmed/34424567 http://dx.doi.org/10.1002/ana.26202

Ejemplares similares

Disrupted balance of T cells under natalizumab treatment in multiple sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2016)

Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2018)

Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis
por: Takewaki, Daiki, et al.
Publicado: (2020)

Involvement of cytotoxic Eomes-expressing CD4(+) T cells in secondary progressive multiple sclerosis
por: Raveney, Ben J. E., et al.
Publicado: (2021)

Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis
por: Takewaki, Daiki, et al.
Publicado: (2018)

Resident Memory-like CD8(+) T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS
por: Kimura, Kimitoshi, et al.
Publicado: (2023)

First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis
por: Sato, Wakiro, et al.
Publicado: (2023)

Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis
por: Akaike, Shun, et al.
Publicado: (2023)

Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
por: Takahashi, Junichiro, et al.
Publicado: (2023)

A multiple sclerosis patient-oriented multiomics analysis tells us where to go next: Commentary for: “Alterations of host-gut microbiome interactions in multiple sclerosis”
por: Yamamura, Takashi, et al.
Publicado: (2022)

Gut microbiota-dependent CCR9(+)CD4(+) T cells are altered in secondary progressive multiple sclerosis
por: Kadowaki, Atsushi, et al.
Publicado: (2019)

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study
por: Lin, Youwei, et al.
Publicado: (2022)

Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder
por: Matsuoka, Takako, et al.
Publicado: (2023)

Application of immunotherapy for neurological manifestations in hypermobile Ehlers–Danlos syndrome
por: Araki, Manabu, et al.
Publicado: (2018)

The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2018)

Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis
por: Vlaic, S, et al.
Publicado: (2017)

Plasmapheresis for systemic vasculitis
por: Fukuoka, Kazuhito, et al.
Publicado: (2022)

A structural MRI study of cholinergic pathways and cognition in multiple sclerosis
por: Kimura, Yukio, et al.
Publicado: (2017)

Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis
por: Suga, Kensuke, et al.
Publicado: (2020)

Possible effects of electroconvulsive therapy on refractory psychosis in primary progressive multiple sclerosis: A case report
por: Narita, Zui, et al.
Publicado: (2018)

Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review
por: Navarro-Martínez, Rut, et al.
Publicado: (2020)

A QUANTITATIVE TECHNIQUE FOR PERFORMING PLASMAPHERESIS
por: Melnick, Daniel, et al.
Publicado: (1936)

Plasmapheresis in Pediatric Intensive Care Unit
por: Misanovic, Verica, et al.
Publicado: (2016)

SUN-573 Plasmapheresis in Thyroid storm
por: Elmahboubi, Riham
Publicado: (2019)

Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning
por: Shariat, Shiva Samsam, et al.
Publicado: (2021)

Impact of plasmapheresis on severe COVID-19
por: Fonseca-González, G., et al.
Publicado: (2023)

Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
por: Zhang, Huayong, et al.
Publicado: (2017)

Medically Refractory Multiple Sclerosis Is Successfully Treated with Plasmapheresis in a Super Morbidly Obese Pregnant Patient
por: Dalka, Lindsey, et al.
Publicado: (2020)

Plasmapheresis and the immunobiology of myasthenia gravis : proceedings of a symposium /
Publicado: (1979)

Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Adult-onset Satoyoshi syndrome and response to plasmapheresis
por: Aghoram, Rajeshwari, et al.
Publicado: (2016)

Salvage Plasmapheresis for Post-hepatectomy Liver Failure
por: Inayat, Faisal, et al.
Publicado: (2016)

Prospects of plasmapheresis for patients with severe COVID-19
por: Gilmutdinova, Ilmira R., et al.
Publicado: (2020)

Plasmapheresis for NMOSD: Not a Rescue Therapy Anymore!?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy
por: Maki, Yohei, et al.
Publicado: (2020)

Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis
por: Miller, Ann, et al.
Publicado: (2019)

Plasmapheresis as a viable treatment option for scleritis
por: Preble, Janine M., et al.
Publicado: (2022)

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
por: Miyake, Sachiko, et al.
Publicado: (2015)

Associations between the oxytocin receptor gene (OXTR) rs53576 polymorphism and emotional processing of social and nonsocial cues: an event-related potential (ERP) study
por: Choi, Damee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ic87p3enudsfta1597dja241e9